Correction to: Blood Cancer Journal https://doi.org/10.1038/s41408-023-00794-x, published online 06 March 2023
Following the publication of this article the authors noted and error in Figure 4, “Kaplan Meier curves for time to next treatment (TTNT) according to sequential MRD measurements”. The figure should have displayed only patients who had MRD taken at least 1 year apart (as defined by IMWG), but instead it incorrectly included an additional 8 patients with sequential measurements taken only at least 6 months apart.
The correct figure shows results based on the first MRD taken at least 1 year apart following day 100 evaluation, and should have appeared as below:
The original article has been corrected.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Fonseca, R., Arribas, M., Wiedmeier-Nutor, J.E. et al. Correction: Integrated analysis of next generation sequencing minimal residual disease (MRD) and PET scan in transplant eligible myeloma patients. Blood Cancer J. 13, 87 (2023). https://doi.org/10.1038/s41408-023-00856-0
Published:
DOI: https://doi.org/10.1038/s41408-023-00856-0
